Fosun International LTD Verrica Pharmaceuticals Inc. Transaction History

Fosun International LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$2.09 - $3.39 $320,595 - $520,009	-153,395 Reduced 54.32%	129,013 $354,000
Q1 2021 May 11, 2021	SELL	$10.51 - $17.46 $437,773 - $727,261	-41,653 Reduced 12.85%	282,408 $4.28 Million
Q1 2020 May 11, 2020	SELL	$7.14 - $16.86 $634,089 - $1.5 Million	-88,808 Reduced 21.51%	324,061 $3.54 Million
Q4 2019 Feb 18, 2020	SELL	$13.08 - $17.43 $4.95 Million - $6.6 Million	-378,543 Reduced 47.83%	412,869 $6.56 Million
Q3 2019 Nov 12, 2019	SELL	$8.65 - $14.81 $24,799 - $42,460	-2,867 Reduced 0.36%	791,412 $11.7 Million
Q3 2018 Nov 09, 2018	SELL	$13.94 - $19.88 $23,976 - $34,193	-1,720 Reduced 0.22%	794,279 $12.9 Million
Q2 2018 Aug 13, 2018	BUY	$17.5 - $20.34 $13.9 Million - $16.2 Million	795,999 New	795,999 $15.7 Million

17.4M

6.1K

6.3K

Ticker VRCA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,094,100
Market Cap $327M
Description
Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.